ReviewFrontiers in pharmacology2018

Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application.

Yandong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.